Israel - English - Ministry of Health

novartis israel ltd - carbamazepine - tablets - carbamazepine 200 mg - carbamazepine - carbamazepine - epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic depressive illness.

Israel - English - Ministry of Health

novartis israel ltd - carbamazepine - tablets slow release - carbamazepine 200 mg - carbamazepine - carbamazepine - epilepsy, trigeminal neuralgia, diabetes insipidus, mania, prophylactic in manic-depressive illness

Malta - English - Medicines Authority

novartis pharmaceuticals uk limited - carbamazepine 200 mg - tablet

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - carbamazepine 200mg;  ;   - modified release tablet - 200 mg - active: carbamazepine 200mg     excipient: carmellose sodium colloidal silicon dioxide ethylcellulose hypromellose yellow, red, white suspension iron oxide red iron oxide yellow magnesium stearate methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil purified talc   purified water titanium dioxide - epilepsy - complex or simple partial seizures (with or without loss of consciousness) with or without secondary generalization. - generalized tonic-clonic seizures. mixed forms of seizures. tegretol® is suitable for both monotherapy and combination therapy. tegretol is usually not effective in absences (petit mal) and myoclonic seizures

United States - English - NLM (National Library of Medicine)

novartis pharmaceuticals corporation - carbamazepine (unii: 33cm23913m) (carbamazepine - unii:33cm23913m) - carbamazepine 100 mg in 5 ml - tegretol is indicated for use as an anticonvulsant drug. evidence supporting efficacy of tegretol as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: - partial seizures with complex symptomatology (psychomotor, temporal lobe). patients with these seizures appear to show greater improvement than those with other types. - generalized tonic-clonic seizures (grand mal). - mixed seizure patterns which include the above, or other partial or generalized seizures. absence seizures (petit mal) do not appear to be controlled by tegretol (see precautions, general). tegretol is indicated in the treatment of the pain associated with true trigeminal neuralgia. beneficial results have also been reported in glossopharyngeal neuralgia. this drug is not a simple analgesic and should not be used for the relief of trivial aches or pains. tegretol should not be used in patients with a history of previous bone marrow depression, hypersensitivity to the drug,

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - carbamazepine - tablet prolonged release - 200 milligram - antiepileptics

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - carbamazepine - tablet prolonged release - 400 milligram - antiepileptics

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis ireland limited - carbamazepine - prolonged-release tablet - 400 milligram(s) - carboxamide derivatives; carbamazepine

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة مستودع الأدوية الأردني - the jordan drugstore co - carbamazepine 400 mg - 400 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - carbamazepine - tablets - 400 milligram - antiepileptics